Compugen Statistics
Total Valuation
Compugen has a market cap or net worth of $224.50 million. The enterprise value is $102.22 million.
| Market Cap | 224.50M |
| Enterprise Value | 102.22M |
Important Dates
The next estimated earnings date is Monday, November 9, 2026, before market open.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Compugen has 94.72 million shares outstanding. The number of shares has increased by 3.76% in one year.
| Current Share Class | 94.72M |
| Shares Outstanding | 94.72M |
| Shares Change (YoY) | +3.76% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 0.22% |
| Owned by Institutions (%) | 16.42% |
| Float | 92.67M |
Valuation Ratios
The trailing PE ratio is 6.38.
| PE Ratio | 6.38 |
| Forward PE | n/a |
| PS Ratio | 3.05 |
| Forward PS | 41.97 |
| PB Ratio | 2.53 |
| P/TBV Ratio | 2.55 |
| P/FCF Ratio | 8.03 |
| P/OCF Ratio | 8.00 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.38, with an EV/FCF ratio of 3.68.
| EV / Earnings | 2.95 |
| EV / Sales | 1.40 |
| EV / EBITDA | 3.38 |
| EV / EBIT | 3.42 |
| EV / FCF | 3.68 |
Financial Position
The company has a current ratio of 5.72, with a Debt / Equity ratio of 0.03.
| Current Ratio | 5.72 |
| Quick Ratio | 5.72 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.10 |
| Debt / FCF | 0.11 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 50.64% and return on invested capital (ROIC) is 26.12%.
| Return on Equity (ROE) | 50.64% |
| Return on Assets (ROA) | 15.46% |
| Return on Invested Capital (ROIC) | 26.12% |
| Return on Capital Employed (ROCE) | 26.18% |
| Weighted Average Cost of Capital (WACC) | 19.32% |
| Revenue Per Employee | $986,680 |
| Profits Per Employee | $469,213 |
| Employee Count | 75 |
| Asset Turnover | 0.60 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Compugen has paid $52,000 in taxes.
| Income Tax | 52,000 |
| Effective Tax Rate | 0.15% |
Stock Price Statistics
The stock price has increased by +70.00% in the last 52 weeks. The beta is 2.79, so Compugen's price volatility has been higher than the market average.
| Beta (5Y) | 2.79 |
| 52-Week Price Change | +70.00% |
| 50-Day Moving Average | 2.46 |
| 200-Day Moving Average | 2.24 |
| Relative Strength Index (RSI) | 43.82 |
| Average Volume (20 Days) | 183,376 |
Short Selling Information
The latest short interest is 2.35 million, so 2.48% of the outstanding shares have been sold short.
| Short Interest | 2.35M |
| Short Previous Month | 3.03M |
| Short % of Shares Out | 2.48% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 6.63 |
Income Statement
In the last 12 months, Compugen had revenue of $74.00 million and earned $35.19 million in profits. Earnings per share was $0.37.
| Revenue | 74.00M |
| Gross Profit | 64.30M |
| Operating Income | 30.30M |
| Pretax Income | 35.24M |
| Net Income | 35.19M |
| EBITDA | 30.68M |
| EBIT | 30.30M |
| Earnings Per Share (EPS) | $0.37 |
Balance Sheet
The company has $125.30 million in cash and $3.02 million in debt, with a net cash position of $122.28 million or $1.29 per share.
| Cash & Cash Equivalents | 125.30M |
| Total Debt | 3.02M |
| Net Cash | 122.28M |
| Net Cash Per Share | $1.29 |
| Equity (Book Value) | 88.73M |
| Book Value Per Share | 0.94 |
| Working Capital | 106.78M |
Cash Flow
In the last 12 months, operating cash flow was $28.25 million and capital expenditures -$116,000, giving a free cash flow of $28.14 million.
| Operating Cash Flow | 28.25M |
| Capital Expenditures | -116,000 |
| Depreciation & Amortization | 380,000 |
| Net Borrowing | n/a |
| Free Cash Flow | 28.14M |
| FCF Per Share | $0.30 |
Margins
Gross margin is 86.89%, with operating and profit margins of 40.94% and 47.55%.
| Gross Margin | 86.89% |
| Operating Margin | 40.94% |
| Pretax Margin | 47.63% |
| Profit Margin | 47.55% |
| EBITDA Margin | 41.45% |
| EBIT Margin | 40.94% |
| FCF Margin | 38.02% |
Dividends & Yields
Compugen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.76% |
| Shareholder Yield | -3.76% |
| Earnings Yield | 15.58% |
| FCF Yield | 12.45% |
Analyst Forecast
The average price target for Compugen is $4.60, which is 94.09% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.60 |
| Price Target Difference | 94.09% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | -37.20% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Compugen has an Altman Z-Score of -0.4 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.4 |
| Piotroski F-Score | 6 |